Rich harvest of new medicines (Pharmalicencing)
The FDA has already approved some very important new therapies this year and more are on the way. For instance, physicians are now able to prescribe a vaccine for the prevention of cervical cancer, the second most common cause of death in women worldwide.

Genentech Announces Third Quarter 2006 Results (FinanzNachrichten)
SOUTH SAN FRANCISCO, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Genentech, ( Nachrichten ) Inc. today announced financial results for the third quarter of 2006. Revenue results for the third quarter of 2006 include:

Brasher: Spinach scare spurs odd merger to help out FDA staff (The Des Moines Register)
Washington, D.C. - All is not well at the Food and Drug Administration, something made clear by the recent spinach scare.